| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Published online before print October 30, 2008
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Immunology,* National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo; and the Department of Neurology and Neurological Sciences, Tokyo Medical and Dental University, Tokyo, Japan
Improved hygiene has been suggested to influence certain autoimmune disorders, such as multiple sclerosis. In this study, we addressed whether altering the composition of gut flora may affect susceptibility to experimental autoimmune encephalomyelitis (EAE), an animal model of MS. We administered a mixture of non-absorbing antibiotics, kanamycin, colistin, and vancomycin (KCV), orally to mice induced to develop EAE. The antibiotic treatment, beginning 1 week prior to sensitization, altered the composition of gut flora and, intriguingly, also ameliorated the development of EAE. While this result was associated with a reduced production of pro-inflammatory cytokines from the draining lymph node cells, a reduction of mesenteric Th17 cells was found to correlate with disease suppression. In addition, we found that V
14 invariant NKT (iNKT) cells were necessary for maintaining the mesenteric Th17 cells. The homologous effects of KCV treatment and iNKT cell depletion led us to speculate that KCV treatment may suppress EAE by altering the function of iNKT cells. Consistent with this hypothesis, KCV treatment did not suppress EAE that was induced in iNKT cell-deficient mice, although it was efficacious in mice that lacked V19 mucosal-associated invariant T cells. Thus, gut flora may influence the development of EAE in a way that is dependent on iNKT cells, which has significant implications for the prevention and treatment of autoimmune diseases.
This article has been cited by other articles:
 |
|
 |
|
  M. K. Arababadi, G. Hassanshahi, H. Azin, V. A. Salehabad, M. Araste, R. Pourali, and Z. Nekhei No Association Between CCR5-{Delta}32 Mutation and Multiple Sclerosis in Patients of Southeastern Iran Lab Med, January 1, 2010; 41(1): 31 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. C. Nichols, W. J. Housley, C. A. O'Conor, T. Manning, S. Wu, and R. B. Clark Unique Lipids from a Common Human Bacterium Represent a New Class of Toll-Like Receptor 2 Ligands Capable of Enhancing Autoimmunity Am. J. Pathol., December 1, 2009; 175(6): 2430 - 2438. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Ochoa-Reparaz, D. W. Mielcarz, L. E. Ditrio, A. R. Burroughs, D. M. Foureau, S. Haque-Begum, and L. H. Kasper Role of Gut Commensal Microflora in the Development of Experimental Autoimmune Encephalomyelitis J. Immunol., November 15, 2009; 183(10): 6041 - 6050. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Fujita, T. Otsuka, M. Mizuno, C. Tomi, T. Yamamura, and S. Miyake Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 Modulates Experimental Autoimmune Encephalomyelitis via an iNKT Cell-Dependent Mechanism Am. J. Pathol., September 1, 2009; 175(3): 1116 - 1123. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. I. Iweala, D. W. Smith, K. S. Matharu, I. Sada-Ovalle, D. D. Nguyen, R. H. DeKruyff, D. T. Umetsu, S. M. Behar, and C. R. Nagler Vaccine-Induced Antibody Isotypes Are Skewed by Impaired CD4 T Cell and Invariant NKT Cell Effector Responses in MyD88-Deficient Mice J. Immunol., August 15, 2009; 183(4): 2252 - 2260. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
